Ellagic acid effects on disease severity, levels of cytokines and T-bet, RORγt, and GATA3 genes expression in multiple sclerosis patients: a multicentral-triple blind randomized clinical trial

Ellagic acid effects on disease severity, levels of cytokines and T-bet, RORγt, and GATA3 genes expression in multiple sclerosis patients: a multicentral-triple blind randomized clinical trial

BackgroundMultiple sclerosis (MS) is a chronic autoimmune disease. Ellagic acid is a natural polyphenol and affects the fate of neurons through its anti-inflammatory and antioxidant properties. The present study aimed to investigate ellagic acid effects on disease severity, the expression of involve...

Full description

Bibliographic Details
Main Authors: Sahar Jafari Karegar, Naheed Aryaeian, Ghazaleh Hajiluian, Katsuhiko Suzuki, Farzad Shidfar, Masoud Salehi, Bahram Haghi Ashtiani, Pooya Farhangnia, Ali-Akbar Delbandi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Nutrition
Subjects:
multiple sclerosis
ellagic acid
pathogenesis
inflammation
disease severity
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2023.1238846/full

Internet

https://www.frontiersin.org/articles/10.3389/fnut.2023.1238846/full

Similar Items